Cargando…
Epidemiology and Clinical Management of Rheumatic Autoimmune Diseases in the COVID-19 Pandemic: A Review
The coronavirus disease 2019 (COVID-19) has been in pandemic for more than 1 year, with serious negative effects produced worldwide. During this period, there have been a lot of studies on rheumatic autoimmune diseases (RADs) combined with COVID-19. The purpose of this study is to review and summari...
Autores principales: | Zhu, Yingzi, Zhong, Jixin, Dong, Lingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416911/ https://www.ncbi.nlm.nih.gov/pubmed/34490312 http://dx.doi.org/10.3389/fmed.2021.725226 |
Ejemplares similares
-
IL-33 in Rheumatic Diseases
por: Dong, Yuanji, et al.
Publicado: (2021) -
Editorial: Rheumatic Diseases and Infection
por: Dong, Lingli, et al.
Publicado: (2022) -
The Role of Decorin in Autoimmune and Inflammatory Diseases
por: Dong, Yuanji, et al.
Publicado: (2022) -
Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic
por: Stradner, Martin H., et al.
Publicado: (2020) -
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice
por: Bosello, Silvia Laura, et al.
Publicado: (2021)